Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji

Introduction. An absolute lymphocyte count is commonly used as an alternative to a CD4 count to determine initiation of antiretroviral therapy for HIV-infected individuals in Fiji when a CD4 count is unavailable. Methods. We conducted a retrospective analysis of laboratory results of HIV-infected in...

Full description

Saved in:
Bibliographic Details
Main Authors: Dashika A. Balak, Karen Bissell, Christine Roseveare, Sharan Ram, Rachel R. Devi, Stephen M. Graham
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2014/715363
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549382818365440
author Dashika A. Balak
Karen Bissell
Christine Roseveare
Sharan Ram
Rachel R. Devi
Stephen M. Graham
author_facet Dashika A. Balak
Karen Bissell
Christine Roseveare
Sharan Ram
Rachel R. Devi
Stephen M. Graham
author_sort Dashika A. Balak
collection DOAJ
description Introduction. An absolute lymphocyte count is commonly used as an alternative to a CD4 count to determine initiation of antiretroviral therapy for HIV-infected individuals in Fiji when a CD4 count is unavailable. Methods. We conducted a retrospective analysis of laboratory results of HIV-infected individuals registered at all HIV clinics in Fiji. Results. Paired absolute lymphocyte and CD4 counts were available for 101 HIV-infected individuals, and 96% had a CD4 count of ≤500 cells/mm3. Correlation between the counts in individuals was poor (Spearman rank correlation r=0.5). No absolute lymphocyte count could be determined in this population as a suitable surrogate for a CD4 count of either 350 cells/mm3 or 500 cells/mm3. The currently used absolute lymphocyte count of ≤2300 cells/μL had a positive predictive value of 87% but a negative predictive value of only 17% for a CD4 of ≤350 cells/mm3 and if used as a surrogate for a CD4 of ≤500 cells/mm3 it would result in all HIV-infected individuals receiving ART including those not yet eligible. Weight, CD4 count, and absolute lymphocyte count increased significantly at 3 months following ART initiation. Conclusions. Our findings do not support the use of absolute lymphocyte count to determine antiretroviral therapy initiation in Fiji.
format Article
id doaj-art-7392fc15e47f4461a75d91cbfb700cba
institution Kabale University
issn 1687-9686
1687-9694
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Tropical Medicine
spelling doaj-art-7392fc15e47f4461a75d91cbfb700cba2025-02-03T06:11:22ZengWileyJournal of Tropical Medicine1687-96861687-96942014-01-01201410.1155/2014/715363715363Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in FijiDashika A. Balak0Karen Bissell1Christine Roseveare2Sharan Ram3Rachel R. Devi4Stephen M. Graham5Reproductive Health Clinic, Ministry of Health, P.O. Box 30, Suva, FijiInternational Union Against Tuberculosis and Lung Disease, 75017 Paris, FranceRegional Public Health Service, Hutt Valley 5010, New ZealandDepartment of Health Science, College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, FijiReproductive Health Clinic, Ministry of Health, P.O. Box 30, Suva, FijiInternational Union Against Tuberculosis and Lung Disease, 75017 Paris, FranceIntroduction. An absolute lymphocyte count is commonly used as an alternative to a CD4 count to determine initiation of antiretroviral therapy for HIV-infected individuals in Fiji when a CD4 count is unavailable. Methods. We conducted a retrospective analysis of laboratory results of HIV-infected individuals registered at all HIV clinics in Fiji. Results. Paired absolute lymphocyte and CD4 counts were available for 101 HIV-infected individuals, and 96% had a CD4 count of ≤500 cells/mm3. Correlation between the counts in individuals was poor (Spearman rank correlation r=0.5). No absolute lymphocyte count could be determined in this population as a suitable surrogate for a CD4 count of either 350 cells/mm3 or 500 cells/mm3. The currently used absolute lymphocyte count of ≤2300 cells/μL had a positive predictive value of 87% but a negative predictive value of only 17% for a CD4 of ≤350 cells/mm3 and if used as a surrogate for a CD4 of ≤500 cells/mm3 it would result in all HIV-infected individuals receiving ART including those not yet eligible. Weight, CD4 count, and absolute lymphocyte count increased significantly at 3 months following ART initiation. Conclusions. Our findings do not support the use of absolute lymphocyte count to determine antiretroviral therapy initiation in Fiji.http://dx.doi.org/10.1155/2014/715363
spellingShingle Dashika A. Balak
Karen Bissell
Christine Roseveare
Sharan Ram
Rachel R. Devi
Stephen M. Graham
Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
Journal of Tropical Medicine
title Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
title_full Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
title_fullStr Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
title_full_unstemmed Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
title_short Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
title_sort absolute lymphocyte count is not a suitable alternative to cd4 count for determining initiation of antiretroviral therapy in fiji
url http://dx.doi.org/10.1155/2014/715363
work_keys_str_mv AT dashikaabalak absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji
AT karenbissell absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji
AT christineroseveare absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji
AT sharanram absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji
AT rachelrdevi absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji
AT stephenmgraham absolutelymphocytecountisnotasuitablealternativetocd4countfordetermininginitiationofantiretroviraltherapyinfiji